Spots Global Cancer Trial Database for circulating tumour dna
Every month we try and update this database with for circulating tumour dna cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Early Detection of Five Common Cancers Using the ctDNA Analysing Test | NCT05227261 | Cancer, Lung Cancer, Breast Cancer Liver Cancer, Colorec... Liquid Biopsy Circulating Tum... Cancer, Gastric | 40 Years - | Gene Solutions | ||
| Early Detection of Five Common Cancers Using the ctDNA Analysing Test | NCT05227261 | Cancer, Lung Cancer, Breast Cancer Liver Cancer, Colorec... Liquid Biopsy Circulating Tum... Cancer, Gastric | 40 Years - | Gene Solutions | ||
| Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE) | NCT06391749 | Cancer Colon Cancer, Liver Cancer, Lung Cancer, Breast Cancer, Gastric | 18 Years - | Gene Solutions | ||
| A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer Patients | NCT03145961 | Triple Negative... | Pembrolizumab | 16 Years - | Institute of Cancer Research, United Kingdom | |
| Selective Internal Radiation Therapy With 90Y Resin Micropheres for Refractory Colorectal Cancer Liver Metastases | NCT04491929 | Liver Metastasi... | 18 Years - | Aarhus University Hospital | ||
| Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE) | NCT06391749 | Cancer Colon Cancer, Liver Cancer, Lung Cancer, Breast Cancer, Gastric | 18 Years - | Gene Solutions | ||
| Cambridge Liquid Biopsy and Tumour Profiling Study for Patients on Experimental Therapeutics Trials | NCT02994511 | Cancer | 18 Years - | Cambridge University Hospitals NHS Foundation Trust | ||
| Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NSCLC. | NCT06167460 | Non Small Cell ... Stage IIIB Non-... Stage IIIC Non-... Stage IV Non-sm... Tyrosine Kinase... | 18 Years - 80 Years | Gene Solutions | ||
| Targeted Radiotherapy in Androgen-suppressed Prostate Cancer Patients. | NCT03644303 | Prostate Cancer Metastasis Toxicity Due to... Circulating Tum... | SBRT + ADT | 18 Years - | Royal Marsden NHS Foundation Trust | |
| Selective Internal Radiation Therapy With 90Y Resin Micropheres for Refractory Colorectal Cancer Liver Metastases | NCT04491929 | Liver Metastasi... | 18 Years - | Aarhus University Hospital | ||
| Personalized Circulating DNA Follow-up in Melanoma (PERCIMEL) | NCT04866680 | Melanoma | Personalized Ci... | 18 Years - | Institut de Cancérologie de Lorraine | |
| Investigate the Prognostic and Predictive Value of ctDNA During Neoadjuvant Chemotherapy for Breast Cancer. | NCT06087120 | Breast Cancer F... Stage II Breast... Stage III Breas... HER2-positive B... Triple Negative... | 18 Years - | Gene Solutions | ||
| Circulating Tumour DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation | NCT04089631 | Colon Cancer St... | Capecitabine | 18 Years - | Technische Universität Dresden | |
| Targeted Radiotherapy in Androgen-suppressed Prostate Cancer Patients. | NCT03644303 | Prostate Cancer Metastasis Toxicity Due to... Circulating Tum... | SBRT + ADT | 18 Years - | Royal Marsden NHS Foundation Trust | |
| Personalized Circulating DNA Follow-up in Melanoma (PERCIMEL) | NCT04866680 | Melanoma | Personalized Ci... | 18 Years - | Institut de Cancérologie de Lorraine | |
| Investigate the Prognostic and Predictive Value of ctDNA During Neoadjuvant Chemotherapy for Breast Cancer. | NCT06087120 | Breast Cancer F... Stage II Breast... Stage III Breas... HER2-positive B... Triple Negative... | 18 Years - | Gene Solutions | ||
| Using a Blood Test to Monitor Metastatic Breast Cancer Treatment | NCT05804578 | Metastatic Brea... | 18 Years - | Queen's University | ||
| CAcTUS - Circulating Tumour DNA Guided Switch | NCT03808441 | Melanoma | ctDNA analysis | 16 Years - | The Christie NHS Foundation Trust |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
